Tema ETFs LLC Sells 3,651 Shares of CME Group Inc. $CME

Tema ETFs LLC reduced its stake in CME Group Inc. (NASDAQ:CME) by 37.8% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 6,017 shares of the financial services provider’s stock after selling 3,651 shares during the period. Tema ETFs LLC’s holdings in CME Group were worth $1,329,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in CME. Vanguard Group Inc. lifted its stake in CME Group by 1.7% in the 4th quarter. Vanguard Group Inc. now owns 35,895,583 shares of the financial services provider’s stock valued at $9,802,366,000 after purchasing an additional 588,509 shares during the last quarter. State Street Corp grew its stake in shares of CME Group by 0.4% during the fourth quarter. State Street Corp now owns 16,144,525 shares of the financial services provider’s stock worth $4,408,747,000 after buying an additional 56,725 shares during the last quarter. Norges Bank acquired a new position in shares of CME Group during the fourth quarter worth $1,523,241,000. Bank of New York Mellon Corp increased its holdings in shares of CME Group by 2.8% during the fourth quarter. Bank of New York Mellon Corp now owns 4,924,475 shares of the financial services provider’s stock worth $1,344,776,000 after buying an additional 134,242 shares in the last quarter. Finally, Raymond James Financial Inc. lifted its stake in shares of CME Group by 5.4% in the 4th quarter. Raymond James Financial Inc. now owns 4,319,763 shares of the financial services provider’s stock valued at $1,179,858,000 after acquiring an additional 222,890 shares during the last quarter. 87.75% of the stock is owned by institutional investors.

Key CME Group News

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME Group averaged a record 27 million contracts traded per day in July. Ongoing uncertainty over inflation, interest rates and geopolitical risks is encouraging hedging and speculative activity across CME’s markets, potentially supporting transaction revenue. CME Group Averaged a Record 27 Million Contracts a Day in July
• Positive Sentiment: The exchange plans to expand 24/7 trading to its 100-ounce silver futures contract, subject to regulatory approval. The move follows strong weekend activity in one-ounce gold futures and could increase participation, liquidity and CME’s reach in precious-metals markets. CME Expands Silver Trading to 24/7
• Positive Sentiment: A Seeking Alpha analysis argues that CME is essential market infrastructure and assigns a “Buy” view, while recent trading volume and the company’s earnings beat reinforce the investment case. CME Group: Buy the Market’s Infrastructure
• Neutral Sentiment: July inflation and wholesale-price data came in softer than expected, causing traders to reassess the likelihood and timing of Federal Reserve rate moves. Easier-policy expectations can support markets, but reduced rate uncertainty could eventually lessen volatility-driven volume. Top Markets Commentator: July Inflation Was Definitely Better Than Expected
• Neutral Sentiment: Planned futures on Nvidia H100 and B200 computing capacity could open a new growth market, although Nvidia’s dominance may limit liquidity and prevent the contracts from becoming a broadly traded commodity. Why Nvidia May Stand in the Way of Wall Street’s Plans to Turn AI Compute Into a Commodity
• Negative Sentiment: Brokerage coverage remains cautious, with CME receiving a consensus “Hold” rating despite some analysts’ optimism. This may limit upside unless trading growth and new products translate into stronger earnings. CME Group Receives Consensus Rating of Hold

Insiders Place Their Bets

In related news, insider Hilda Harris Piell sold 5,753 shares of the business’s stock in a transaction on Monday, May 18th. The shares were sold at an average price of $304.63, for a total value of $1,752,536.39. Following the transaction, the insider owned 27,702 shares in the company, valued at $8,438,860.26. The trade was a 17.20% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director William R. Shepard purchased 325 shares of the business’s stock in a transaction on Thursday, June 25th. The shares were purchased at an average cost of $230.57 per share, for a total transaction of $74,935.25. Following the transaction, the director directly owned 260,442 shares of the company’s stock, valued at approximately $60,050,111.94. The trade was a 0.12% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. 0.30% of the stock is owned by company insiders.

Analyst Ratings Changes

CME has been the topic of several recent research reports. Bank of America raised their price objective on CME Group from $226.00 to $230.00 and gave the company an “underperform” rating in a report on Thursday, July 23rd. Rothschild & Co Redburn raised CME Group from a “neutral” rating to a “buy” rating and upped their target price for the stock from $316.00 to $323.00 in a report on Thursday, June 11th. Erste Group Bank downgraded CME Group from a “buy” rating to a “hold” rating in a research report on Friday, June 5th. Wall Street Zen cut CME Group from a “sell” rating to a “strong sell” rating in a report on Saturday, August 1st. Finally, Keefe, Bruyette & Woods upgraded shares of CME Group from a “market perform” rating to an “outperform” rating and set a $305.00 price objective for the company in a report on Thursday, June 18th. Ten research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and three have assigned a Sell rating to the company. According to MarketBeat.com, CME Group has an average rating of “Hold” and an average price target of $291.81.

CME Group Price Performance

CME Group stock opened at $267.21 on Friday. The stock’s 50 day moving average is $249.95 and its 200 day moving average is $280.29. CME Group Inc. has a one year low of $218.31 and a one year high of $329.16. The firm has a market cap of $96.08 billion, a P/E ratio of 22.66, a P/E/G ratio of 3.05 and a beta of 0.23. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02.

CME Group (NASDAQ:CME) last released its earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share for the quarter, beating analysts’ consensus estimates of $2.91 by $0.08. The business had revenue of $1.71 billion during the quarter, compared to the consensus estimate of $1.68 billion. CME Group had a net margin of 63.30% and a return on equity of 15.60%. The company’s revenue for the quarter was up .8% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.96 EPS. As a group, research analysts expect that CME Group Inc. will post 12.27 EPS for the current year.

CME Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, September 25th. Investors of record on Wednesday, September 9th will be paid a dividend of $1.30 per share. This represents a $5.20 dividend on an annualized basis and a yield of 1.9%. The ex-dividend date of this dividend is Wednesday, September 9th. CME Group’s dividend payout ratio (DPR) is currently 44.11%.

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.